T Cell Immunotherapies/Corticosteroids Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Corticosteroids may prevent your body's immune system from responding to your oncology treatment.
What might happen:
If you are taking corticosteroids while you are receiving therapy with axicabtagene, brexucabtagene, or tisagenlecleucel, your oncology treatment may not work as well.
What you should do about this interaction:
Let your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together or if you have taken corticosteroids recently before you receive axicabtagene, brexucabtagene, or tisagenlecleucel.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Kymriah (tisagenlecleucel) US prescribing information. Novartis Pharmaceuticals Corporation August, 2017.
- 2.Yescarta (axicabtagene ciloleucel) US prescribing information. Kite Pharma, Inc. October, 2017.
- 3.Tecartus (brexucabtagene autoleucel) US prescribing information. Kite Pharma July, 2020.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.